Literature DB >> 15342520

Phenotypic variation resulting from a deficiency of epidermal growth factor receptor in mice is caused by extensive genetic heterogeneity that can be genetically and molecularly partitioned.

Karen E Strunk1, Vicky Amann, David W Threadgill.   

Abstract

The timing of lethality caused by homozygosity for a null allele of the epidermal growth factor receptor (Egfrtm1Mag) in mice is strongly dependent on genetic background. Initial attempts to genetically map background modifiers using Swiss-derived, outbred CD-1 mice were unsuccessful. To investigate the genetic architecture contributing to survival of Egfrtm1Mag homozygous embryos, the genetic variability segregating within the outbred population was partitioned by surveying viability of Egfrtm1Mag mutants using intercrosses between 129S6/SvEvTAC-Egfrtm1Mag and nine Swiss-derived, inbred strains: ALR/LtJ, ALS/LtJ, APN, APS, ICR/HaRos, NOD/LtJ, NON/LtJ, SJL/J, and SWR/J. The observations showed that these strains support varying levels of survival of Egfrtm1Mag homozygous embryos, suggesting that genetic heterogeneity within the CD-1 stock contributed to the original lack of Egfrtm1Mag modifier detection. Similar to the Swiss-derived intercrosses, nine congenic strains, derived from 129S6/SvEvTAC, AKR/J, APN, BALB/cJ, BTBR-T+ tf/tf, C3H/HeJ, C57BL/6J, DBA/2J, and FVB/NJ inbred backgrounds, also supported varying levels of survival of Egfrtm1Mag mutants. By intercrossing the congenic lines to create hybrid F1 embryos, different genetic backgrounds were found to have complementary modifiers. Analysis of the congenic lines argues against heterosis of outbred backgrounds contributing to Egfrtm1Mag phenotypic variability. A detailed analysis of the crosses suggests that modifiers function at three distinct stages of development. One class of modifiers supports survival of Egfrtm1Mag homozygous embryos to mid-gestation, another class supports development through the mid-gestation transition from yolk-sac to placental-derived nutrient sources, and a third class supports survival through later stages of gestation. Data from microarray analysis using RNA from wild-type and Egfrtm1Mag mutant placentas support the existence of extensive genetic heterogeneity and suggest that it can be molecularly partitioned. This method should be generally useful to partition heterogeneity contributing to other complex traits. Copyright 2004 Genetics Society of America

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342520      PMCID: PMC1470975          DOI: 10.1534/genetics.103.020495

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  33 in total

1.  Genetical genomics: the added value from segregation.

Authors:  R C Jansen; J P Nap
Journal:  Trends Genet       Date:  2001-07       Impact factor: 11.639

2.  Combining mapping and arraying: An approach to candidate gene identification.

Authors:  M L Wayne; L M McIntyre
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

3.  Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily.

Authors:  L Strachan; J G Murison; R L Prestidge; M A Sleeman; J D Watson; K D Kumble
Journal:  J Biol Chem       Date:  2001-01-16       Impact factor: 5.157

Review 4.  Clinical trial design and end points for epidermal growth factor receptor-targeted therapies: implications for drug development and practice.

Authors:  Carlos L Arteaga; Jose Baselga
Journal:  Clin Cancer Res       Date:  2003-05       Impact factor: 12.531

5.  Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients.

Authors:  Y Umekita; Y Ohi; Y Sagara; H Yoshida
Journal:  Int J Cancer       Date:  2000-11-20       Impact factor: 7.396

6.  Genealogies of mouse inbred strains.

Authors:  J A Beck; S Lloyd; M Hafezparast; M Lennon-Pierce; J T Eppig; M F Festing; E M Fisher
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

7.  Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.

Authors:  D S Rickman; M P Bobek; D E Misek; R Kuick; M Blaivas; D M Kurnit; J Taylor; S M Hanash
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

8.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

Authors:  C M Perou; S S Jeffrey; M van de Rijn; C A Rees; M B Eisen; D T Ross; A Pergamenschikov; C F Williams; S X Zhu; J C Lee; D Lashkari; D Shalon; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

9.  Biomarker conservation in primary and metastatic epithelial ovarian cancer.

Authors:  K S Tewari; A S Kyshtoobayeva; R S Mehta; I R Yu; R A Burger; P J DiSaia; J P Fruehauf
Journal:  Gynecol Oncol       Date:  2000-08       Impact factor: 5.482

10.  NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds.

Authors:  E H Leiter; P C Reifsnyder; K Flurkey; H J Partke; E Junger; L Herberg
Journal:  Diabetes       Date:  1998-08       Impact factor: 9.461

View more
  20 in total

Review 1.  ADAM Proteases and Gastrointestinal Function.

Authors:  Jennifer C Jones; Shelly Rustagi; Peter J Dempsey
Journal:  Annu Rev Physiol       Date:  2015-11-19       Impact factor: 19.318

2.  Placental and embryonic growth restriction in mice with reduced function epidermal growth factor receptor alleles.

Authors:  Jennifer Dackor; Kathleen M Caron; David W Threadgill
Journal:  Genetics       Date:  2009-06-29       Impact factor: 4.562

3.  A Chimeric Egfr Protein Reporter Mouse Reveals Egfr Localization and Trafficking In Vivo.

Authors:  Yu-Ping Yang; Haiting Ma; Alina Starchenko; Won Jae Huh; Wei Li; F Edward Hickman; Qin Zhang; Jeffrey L Franklin; Douglas P Mortlock; Sabine Fuhrmann; Bruce D Carter; Rebecca A Ihrie; Robert J Coffey
Journal:  Cell Rep       Date:  2017-05-09       Impact factor: 9.423

4.  Loss of hepatocyte EGFR has no effect alone but exacerbates carbon tetrachloride-induced liver injury and impairs regeneration in hepatocyte Met-deficient mice.

Authors:  Lawrence A Scheving; Xiuqi Zhang; Mary C Stevenson; David W Threadgill; William E Russell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-11-20       Impact factor: 4.052

Review 5.  Does your gene need a background check? How genetic background impacts the analysis of mutations, genes, and evolution.

Authors:  Christopher H Chandler; Sudarshan Chari; Ian Dworkin
Journal:  Trends Genet       Date:  2013-02-28       Impact factor: 11.639

6.  Altered trophoblast proliferation is insufficient to account for placental dysfunction in Egfr null embryos.

Authors:  J Dackor; K E Strunk; M M Wehmeyer; D W Threadgill
Journal:  Placenta       Date:  2007-09-05       Impact factor: 3.481

7.  Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice.

Authors:  Cordelia J Barrick; Reade B Roberts; Mauricio Rojas; Nalini M Rajamannan; Carolyn B Suitt; Kevin D O'Brien; Susan S Smyth; David W Threadgill
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-15       Impact factor: 4.733

8.  Deficiency of TNFalpha converting enzyme (TACE/ADAM17) causes a lean, hypermetabolic phenotype in mice.

Authors:  Richard W Gelling; Wenbo Yan; Salwa Al-Noori; Aaron Pardini; Gregory J Morton; Kayoko Ogimoto; Michael W Schwartz; Peter J Dempsey
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

9.  Extraembryonic heparin-binding epidermal growth factor-like growth factor deficiency compromises placentation in mice.

Authors:  Zitao Liu; Debra F Skafar; Brian Kilburn; Sanjoy K Das; D Randall Armant
Journal:  Biol Reprod       Date:  2019-01-01       Impact factor: 4.285

10.  Wa5 is a novel ENU-induced antimorphic allele of the epidermal growth factor receptor.

Authors:  Daekee Lee; Sally H Cross; Karen E Strunk; Joanne E Morgan; Candice L Bailey; Ian J Jackson; David W Threadgill
Journal:  Mamm Genome       Date:  2004-07       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.